McKinsey Global Institute has projected that by 2030, 50% of the world’s population will be obese and the annual cost of Obesity-related disease expenditures will have risen to $17,000,000,000,000.
An article in the Arab News reported that 70% of the Saudi’s are obese. With Obesity and Type 2 Diabetes galloping along in developed nations, the terrifying fact is that McKinsey’s projections may underestimate the problem!
Let us hope that, by allowing us to directly and safely remove the visceral fat that is the origin of the problem, Endoscopic Visceral Lipectomy (“EVL”) can avoid the progression of Obesity and Type 2 Diabetes and reverse it, and give us a weapon to slow the rising prevalence of this disease. I entreat all reading this post to help make BioSculpture Technology’s DPO a success so we may be able to offer EVL to the 2.1 Billion people about the globe who may benefit from it. Your investment may be both impactful and profitable.